β¨ Medicines Act Notices
16 NOVEMBER NEW ZEALAND GAZETTE 3993
Health
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Pralidoxime Iodide (PAM)
Active Ingredient(s): Pralidoxime iodide 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer(s): Abbott Australasia Pty Limited, Captain Cook Drive, Kurnell, New South Wales, Australia
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 8th day of November 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go8428
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Neurontin
Active Ingredient(s): Gabapentin 100mg
Dosage Form: Capsule
New Zealand Sponsor: Parke Davis (Division Warner Lambert NZ Limited)
Manufacturer(s): Godecke AG, Freiburg, Germany
Product: Neurontin
Active Ingredient(s): Gabapentin 300mg
Dosage Form: Capsule
New Zealand Sponsor: Parke Davis (Division Warner Lambert NZ Limited)
Manufacturer(s): Godecke AG, Freiburg, Germany
Product: Neurontin
Active Ingredient(s): Gabapentin 400mg
Dosage Form: Capsule
New Zealand Sponsor: Parke Davis (Division Warner Lambert NZ Limited)
Manufacturer(s): Godecke AG, Freiburg, Germany
Product: Neurontin
Active Ingredient(s): Gabapentin 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Parke Davis (Division Warner Lambert NZ Limited)
Manufacturer(s): Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Product: Neurontin
Active Ingredient(s): Gabapentin 800mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Parke Davis (Division Warner Lambert NZ Limited)
Manufacturer(s): Warner-Lambert Inc, Vega Baja, Puerto Rico
Dated this 8th day of November 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go8427
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 154
Gazette.govt.nz —
NZ Gazette 2000, No 154
β¨ LLM interpretation of page content
π₯ Provisional Consent to Distribute New Medicine
π₯ Health & Social Welfare8 November 2000
Medicines Act, Provisional Consent, Pralidoxime Iodide, Abbott Laboratories
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribute Changed Medicines
π₯ Health & Social Welfare8 November 2000
Medicines Act, Changed Medicines, Neurontin, Gabapentin, Parke Davis
- G. R. Boyd, Chief Advisor, Safety and Regulation